Age-standardized mortality rates related to viral hepatitis in Brazil

Abstract Background Liver-related mortality has been increasing worldwide. We aimed to estimate the age-standardized mortality rates from viral hepatitis in Brazil. Methods The Brazilian National Death Registry was analyzed from 2008 to 2014. Viral hepatitis deaths were defined by the following ICD-...

Full description

Bibliographic Details
Main Authors: Hugo Perazzo, Antonio G Pacheco, Paula M Luz, Rodolfo Castro, Chris Hyde, Juliana Fittipaldi, Caroline Rigolon, Sandra W Cardoso, Beatriz Grinsztejn, Valdiléa G Veloso
Format: Article
Language:English
Published: BMC 2017-07-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-017-2619-y
_version_ 1819114922885251072
author Hugo Perazzo
Antonio G Pacheco
Paula M Luz
Rodolfo Castro
Chris Hyde
Juliana Fittipaldi
Caroline Rigolon
Sandra W Cardoso
Beatriz Grinsztejn
Valdiléa G Veloso
author_facet Hugo Perazzo
Antonio G Pacheco
Paula M Luz
Rodolfo Castro
Chris Hyde
Juliana Fittipaldi
Caroline Rigolon
Sandra W Cardoso
Beatriz Grinsztejn
Valdiléa G Veloso
author_sort Hugo Perazzo
collection DOAJ
description Abstract Background Liver-related mortality has been increasing worldwide. We aimed to estimate the age-standardized mortality rates from viral hepatitis in Brazil. Methods The Brazilian National Death Registry was analyzed from 2008 to 2014. Viral hepatitis deaths were defined by the following ICD-10 codes in the death certificate: hepatitis A [B15.0; B15.9]; hepatitis B [B16.2; B16.9; B18.1]; hepatitis C [B17.1; B18.2]; hepatitis Delta [B16.0; B16.1; B18.0; B17.0] and other viral hepatitis [B17.2; B17.8; B18.8; B18.9; B19.0; B19.9]. Crude mortality rates were calculated by the ratio between total number of deaths and estimated population. Mortality rates were age-standardized by the direct method using the WHO standard population. Results Thirty four thousand ,nine hundred seventy eight deaths had viral hepatitis mentioned in their death certificate [65% male, aged 58 years, 73% associated with hepatitis C]. Age-standardized mortality rate (95% CI) due to viral hepatitis was 2.695 (2.667–2.724) deaths per 100,000 inhabitants: South region had the higher rates [3.997 (3.911–4.085)]. Mortality rates associated with hepatitis A and Delta were 0.032 (0.029–0.035) and 0.028 (0.025–0.031), respectively. Hepatitis C mortality rates were 4-fold higher than those associated with hepatitis B [1.964 (1.940–1.989) vs 0.500 (0.488–0.512)]. South region had the higher rates for hepatitis C [3.163 (3.087–3.241)] and North had the higher rates for hepatitis A [0.066 (0.049–0.087)], B [0.986 (0.918–1.058)] and Delta [0.220 (0.190–0.253)]. Conclusion Viral hepatitis remains a major public health issue in Brazil. Mortality rates were not homogeneous across the country, suggesting that health policies should be customized according to geographical location.
first_indexed 2024-12-22T04:53:00Z
format Article
id doaj.art-bb70336071f94c7cb567962be414eac3
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-22T04:53:00Z
publishDate 2017-07-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-bb70336071f94c7cb567962be414eac32022-12-21T18:38:26ZengBMCBMC Infectious Diseases1471-23342017-07-0117111010.1186/s12879-017-2619-yAge-standardized mortality rates related to viral hepatitis in BrazilHugo Perazzo0Antonio G Pacheco1Paula M Luz2Rodolfo Castro3Chris Hyde4Juliana Fittipaldi5Caroline Rigolon6Sandra W Cardoso7Beatriz Grinsztejn8Valdiléa G Veloso9Fundação Oswaldo Cruz (FIOCRUZ), Instituto Nacional de Infectologia Evandro Chagas (INI), Laboratório de Pesquisa Clínica em DST e AIDS (LAPCLIN-AIDS)Fundação Oswaldo Cruz (FIOCRUZ), Programa de Computação Científica (PROCC)Fundação Oswaldo Cruz (FIOCRUZ), Instituto Nacional de Infectologia Evandro Chagas (INI), Laboratório de Pesquisa Clínica em DST e AIDS (LAPCLIN-AIDS)Fundação Oswaldo Cruz (FIOCRUZ), Instituto Nacional de Infectologia Evandro Chagas (INI), Laboratório de Pesquisa Clínica em DST e AIDS (LAPCLIN-AIDS)Institute of Health Research, Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis and Modelling for Health Improvement (ESMI), University of Exeter Medical School, University of ExeterFundação Oswaldo Cruz (FIOCRUZ), Instituto Nacional de Infectologia Evandro Chagas (INI), Laboratório de Pesquisa Clínica em DST e AIDS (LAPCLIN-AIDS)Fundação Oswaldo Cruz (FIOCRUZ), Instituto Nacional de Infectologia Evandro Chagas (INI), Laboratório de Pesquisa Clínica em DST e AIDS (LAPCLIN-AIDS)Fundação Oswaldo Cruz (FIOCRUZ), Instituto Nacional de Infectologia Evandro Chagas (INI), Laboratório de Pesquisa Clínica em DST e AIDS (LAPCLIN-AIDS)Fundação Oswaldo Cruz (FIOCRUZ), Instituto Nacional de Infectologia Evandro Chagas (INI), Laboratório de Pesquisa Clínica em DST e AIDS (LAPCLIN-AIDS)Fundação Oswaldo Cruz (FIOCRUZ), Instituto Nacional de Infectologia Evandro Chagas (INI), Laboratório de Pesquisa Clínica em DST e AIDS (LAPCLIN-AIDS)Abstract Background Liver-related mortality has been increasing worldwide. We aimed to estimate the age-standardized mortality rates from viral hepatitis in Brazil. Methods The Brazilian National Death Registry was analyzed from 2008 to 2014. Viral hepatitis deaths were defined by the following ICD-10 codes in the death certificate: hepatitis A [B15.0; B15.9]; hepatitis B [B16.2; B16.9; B18.1]; hepatitis C [B17.1; B18.2]; hepatitis Delta [B16.0; B16.1; B18.0; B17.0] and other viral hepatitis [B17.2; B17.8; B18.8; B18.9; B19.0; B19.9]. Crude mortality rates were calculated by the ratio between total number of deaths and estimated population. Mortality rates were age-standardized by the direct method using the WHO standard population. Results Thirty four thousand ,nine hundred seventy eight deaths had viral hepatitis mentioned in their death certificate [65% male, aged 58 years, 73% associated with hepatitis C]. Age-standardized mortality rate (95% CI) due to viral hepatitis was 2.695 (2.667–2.724) deaths per 100,000 inhabitants: South region had the higher rates [3.997 (3.911–4.085)]. Mortality rates associated with hepatitis A and Delta were 0.032 (0.029–0.035) and 0.028 (0.025–0.031), respectively. Hepatitis C mortality rates were 4-fold higher than those associated with hepatitis B [1.964 (1.940–1.989) vs 0.500 (0.488–0.512)]. South region had the higher rates for hepatitis C [3.163 (3.087–3.241)] and North had the higher rates for hepatitis A [0.066 (0.049–0.087)], B [0.986 (0.918–1.058)] and Delta [0.220 (0.190–0.253)]. Conclusion Viral hepatitis remains a major public health issue in Brazil. Mortality rates were not homogeneous across the country, suggesting that health policies should be customized according to geographical location.http://link.springer.com/article/10.1186/s12879-017-2619-yLiver diseaseHepatitisDeath ratesAge-standardized mortality
spellingShingle Hugo Perazzo
Antonio G Pacheco
Paula M Luz
Rodolfo Castro
Chris Hyde
Juliana Fittipaldi
Caroline Rigolon
Sandra W Cardoso
Beatriz Grinsztejn
Valdiléa G Veloso
Age-standardized mortality rates related to viral hepatitis in Brazil
BMC Infectious Diseases
Liver disease
Hepatitis
Death rates
Age-standardized mortality
title Age-standardized mortality rates related to viral hepatitis in Brazil
title_full Age-standardized mortality rates related to viral hepatitis in Brazil
title_fullStr Age-standardized mortality rates related to viral hepatitis in Brazil
title_full_unstemmed Age-standardized mortality rates related to viral hepatitis in Brazil
title_short Age-standardized mortality rates related to viral hepatitis in Brazil
title_sort age standardized mortality rates related to viral hepatitis in brazil
topic Liver disease
Hepatitis
Death rates
Age-standardized mortality
url http://link.springer.com/article/10.1186/s12879-017-2619-y
work_keys_str_mv AT hugoperazzo agestandardizedmortalityratesrelatedtoviralhepatitisinbrazil
AT antoniogpacheco agestandardizedmortalityratesrelatedtoviralhepatitisinbrazil
AT paulamluz agestandardizedmortalityratesrelatedtoviralhepatitisinbrazil
AT rodolfocastro agestandardizedmortalityratesrelatedtoviralhepatitisinbrazil
AT chrishyde agestandardizedmortalityratesrelatedtoviralhepatitisinbrazil
AT julianafittipaldi agestandardizedmortalityratesrelatedtoviralhepatitisinbrazil
AT carolinerigolon agestandardizedmortalityratesrelatedtoviralhepatitisinbrazil
AT sandrawcardoso agestandardizedmortalityratesrelatedtoviralhepatitisinbrazil
AT beatrizgrinsztejn agestandardizedmortalityratesrelatedtoviralhepatitisinbrazil
AT valdileagveloso agestandardizedmortalityratesrelatedtoviralhepatitisinbrazil